Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.

Literature DB >> 19945118

Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.

Castigliano M Bhamidipati¹, Gorav Ailawadi, James Bergin, John A Kern.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Anticoagulants

Year: 2009 PMID： 19945118 PMCID： PMC2891613 DOI： 10.1016/j.jtcvs.2009.09.046

Source DB: PubMed Journal: J Thorac Cardiovasc Surg ISSN： 0022-5223 Impact factor: 5.209

× No keyword cloud information.

5 in total

1. A successful anticoagulation protocol for the first HeartMate II implantation in the United States.

Authors: Offer Amir; Arthur W Bracey; Frank W Smart; Reynolds M Delgado; Nyma Shah; Biswajit Kar
Journal: Tex Heart Inst J Date: 2005

2. Thrombus formation in a HeartMate II left ventricular assist device.

Authors: Anna Lassia Meyer; Christian Kuehn; Jürgen Weidemann; Doris Malehsa; Christoph Bara; Stefan Fischer; Axel Haverich; Martin Strüber
Journal: J Thorac Cardiovasc Surg Date: 2008-01 Impact factor: 5.209

3. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).

Authors: Jolanta Klovaite; Finn Gustafsson; Svend A Mortensen; Kåre Sander; Lars B Nielsen
Journal: J Am Coll Cardiol Date: 2009-06-09 Impact factor: 24.094

4. Association of device surface and biomaterials with immunologic sensitization after mechanical support.

Authors: Isaac George; Patrick Colley; Mark J Russo; Timothy P Martens; Elizabeth Burke; Mehmet C Oz; Mario C Deng; Donna M Mancini; Yoshifumi Naka
Journal: J Thorac Cardiovasc Surg Date: 2008-06 Impact factor: 5.209

5. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.

Authors: Ranjit John; Forum Kamdar; Kenneth Liao; Monica Colvin-Adams; Leslie Miller; Lyle Joyce; Andrew Boyle
Journal: J Thorac Cardiovasc Surg Date: 2008-09-14 Impact factor: 5.209

5 in total

6 in total

1. New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices.

Authors: Donna Mancini; Juan Monteagudo; Mayte Suárez-Fariñas; Jeffrey Bander; Rohan Varshney; Juana Gonzalez; Barry S Coller; Jasimuddin Ahamed
Journal: Transl Res Date: 2017-11-05 Impact factor: 7.012

Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.

1. A successful anticoagulation protocol for the first HeartMate II implantation in the United States.

2. Thrombus formation in a HeartMate II left ventricular assist device.

3. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).

4. Association of device surface and biomaterials with immunologic sensitization after mechanical support.

5. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.

1. New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices.

2. Pre-implant left ventricular apex position predicts risk of HeartMate II pump thrombosis.

3. Resolution of hemolysis from pump thrombus during left ventricular assist device exchange.

4. High-speed visualization of disturbed pathlines in axial flow ventricular assist device under pulsatile conditions.

5. Dysphagia in the setting of left ventricular assist device hemolysis.

6. Influence of shear rate and surface chemistry on thrombus formation in micro-crevice.